The impact of home treatment and self-administration of omalizumab on chronic urticaria

https://www.sciencedirect.com/science/article/pii/S1939455122001016

World Allergy Organization Journal, Volume 15, Issue 12, December 2022, 100725

Anne Christine Wiuff, Malthe Alexander Knudsgaard Wiis, Sofine Heilskov, Anne Sofie Frølunde, Jennifer Astrup Sørensen, Mette Deleuran, Simon Francis Thomsen, Christian Vestergaard

Abstract

Background

Patients suffering from Chronic Spontaneous Urticaria (CSU) may be recalcitrant to treatment with high dose second-generation antihistamines. These patients are, according to international guidelines, eligible to treatment with omalizumab. Treatment with omalizumab has proven to be very effective for this group of patients. Until 2018, when the self-administration of omalizumab was approved, patients have had to visit an outpatient clinic to receive the treatment.

Methods

In this study we performed a survey among 75 CSU patients who had changed their treatment from administration at an outpatient clinic to self-administration at home.

Results

None of the patients experienced decreased effect of the treatment with omalizumab, whereas 41.4% reported improved effect of the treatment during self-administration.

The most common reported benefits for the patients were decreased travel time and the ability to choose dosing time at the day of treatment, whereas the most reported concern was fear of performing the injection.

Conclusions

Patients are very content with self-administration of omalizumab. There has been no decreased effect of the treatment, and as discussed in this paper, there might be other societal benefits from self-administration. Thus, self-administration at home of omalizumab should be standard of care when using this treatment.

Keywords: Chronic spontaneous urticarial Omalizumab Self-administration Home-treatment Patient satisfaction

Virus-free.www.avast.com

About mastopedia

Mastopedia moderates information on Mastocytosis, Urticaria Pigmentosa, Mast Cell Activation Disorder / Syndrome, Idiopathic Anaphylaxis and related disorders. www.mastopedia.com
This entry was posted in Uncategorized. Bookmark the permalink.

1 Response to The impact of home treatment and self-administration of omalizumab on chronic urticaria

  1. mary barrett says:

    After almost a year of taking monthly injections of Omalizumab, in a hospital setting I did notice an improvement of my nasal mucosa inflammation.
    However, the mast cell rash “Freckles “ have not resolved, I did discontinue the injections. To this day, my nasal breathing has maintained this level, making easier to breathe.

Leave a comment